Cargando…
Case Series of Creatine Deficiency Syndrome due to Guanidinoacetate Methyltransferase Deficiency
Guanidinoacetate methyltransferase (GAMT) deficiency is the second most common defect in the creatine metabolism pathway resulting in cerebral creatine deficiency syndrome (CCDS). We report three patients from two unrelated families, diagnosed with GAMT deficiency on next-generation sequencing. All...
Autores principales: | Narayan, Vinu, Mahay, Sunita Bijarnia, Verma, Ishwar Chander, Puri, Ratna Dua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313580/ https://www.ncbi.nlm.nih.gov/pubmed/32606525 http://dx.doi.org/10.4103/aian.AIAN_367_18 |
Ejemplares similares
-
Mutation–Proved Clouston Syndrome in a Large Indian Family with a Variant Phenotype
por: Khatter, Sangeeta, et al.
Publicado: (2019) -
Challenges in Chronic Genetic Disorders: Lessons From the COVID-19 Pandemic
por: Pal, Swasti, et al.
Publicado: (2021) -
Guanidinoacetate Methyltransferase (GAMT) Deficiency, A Cerebral Creatine Deficiency Syndrome: A Rare Treatable Metabolic Disorder
por: Yoganathan, Sangeetha, et al.
Publicado: (2020) -
Prenatal presentation of a rare genetic disorder: a clinical, autopsy and molecular correlation
por: Arora, Veronica, et al.
Publicado: (2019) -
Gene therapy for guanidinoacetate methyltransferase deficiency restores cerebral and myocardial creatine while resolving behavioral abnormalities
por: Khoja, Suhail, et al.
Publicado: (2022)